IL7 and tuberculosis: In this study, we designed and constructed experimental rBCG vaccine candidates coexpressing either human IL-7 or IL-18 in the genetic background of BCG ΔureC::hly, a TB vaccine candidate that is in phase IIa clinical development [11] (ClinicalTrial.gov, #NCT01479972).